Skip to main content
. 2022 Aug 7;25(6):989–1001. doi: 10.1007/s10120-022-01326-5

Table 3.

One-year-, 3-year-, and 5-year survival in histologically confirmed gastric adenocarcinoma (non-cardia and cardia) stratified by cancer stage during 1987–2016

Gastric non-cardia adenocarcinoma Gastric cardia adenocarcinoma
Patients Survival in % Patients Survival in %
Calendar period Number (%) 1 year 3 years 5 years Number (%) 1 year 3 years 5 years
Local
 1987–1991 1092 (30.3) 74 55 45 147 (24.5) 64 32 26
 1992–1996 960 (26.6) 79 59 48 150 (25.0) 62 42 33
 1997–2001 609 (16.9) 78 60 52 107 (17.9) 68 43 35
 2002–2006 488 (13.5) 78 60 50 85 (14.2) 71 49 37
 2007–2011 351 (9.7) 74 58 50 88 (14.7) 62 48 34
 2012–2016 108 (3.0) 79 62 57 22 (3.7) 73 54 55
Locally advanced
 1987–1991 505 (22.7) 61 26 17 83 (17.7) 46 11 5
 1992–1996 447 (20.1) 62 28 20 91 (19.4) 57 19 12
 1997–2001 459 (20.6) 68 34 23 116 (24.7) 68 32 23
 2002–2006 350 (15.7) 72 40 31 61 (13.0) 74 33 26
 2007–2011 267 (12.0) 80 44 28 80 (17.1) 82 46 28
 2012–2016 198 (8.9) 66 35 26 38 (8.1) 76 37 24
Advanced
 1987–1991 1892 (24.9) 16 3 2 290 (20.0) 14 2 1
 1992–1996 1472 (19.3) 15 2 2 278 (19.1) 18 4 3
 1997–2001 1203 (15.8) 16 4 3 258 (17.8) 18 3 1
 2002–2006 1286 (16.9) 23 6 3 263 (18.1) 24 5 3
 2007–2011 1243 (16.3) 30 12 7 273 (18.8) 34 8 6
 2012–2016 514 (6.8) 18 4 3 90 (6.2) 20 6 4